Your account is not claimed yet. You can sign up with ORCID to claim your account.

Manuel Cobo (M Á Cobo, Manuel Cobo-Dols, Manuel Cobo Dols)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 13

Top Venues

Journal of clinical medicine

Cancers

BMJ supportive & palliative care

Biomedicines

Hospital Regional Universitario de Málaga

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Regional Universitario de Málaga Dec 19o 1999

Spain

md, phd :: medical oncology

Publications

Dolores Isla, Alfredo Sánchez, Joaquín Casal, Manuel Cobo, Margarita Majem Tarruella, Noemi Reguart, Jon Zugazagoitia, Reyes Bernabé
PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement. Journal of clinical medicine 12 (15) (2023)
Javier Oliver, Juan-Luis Onieva-Zafra, María Garrido-Barros, Manuel Cobo, Beatriz Martínez-Gálvez, Ana Isabel García-Pelícano, Jaime Dubbelman, José Carlos Benítez, Juan Zafra Martín, Alejandra Cantero, Elisabeth Perez-Ruiz, Antonio Rueda Domínguez, Isabel Barragán
Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade. Cancers 15 (13) (2023)
Raquel Laza-Briviesca, Alberto Cruz-Bermúdez, Ernest Nadal, Amelia Insa, María Del Rosario García-Campelo, Gerardo Huidobro, Manuel Dómine, Margarita Majem Tarruella, Delvys Rodríguez-Abreu, Alex Martinez-Marti, Javier De Castro Carpeño, Manuel Cobo, Guillermo López-Vivanco, Elvira Del Barco, Reyes Bernabé, Nuria Viñolas, Isidoro Barneto Aranda, Santiago Viteri, Bartomeu Massuti, Marta Casarrubios, Belén Sierra-Rodero, Carlos Tarín, Aránzazu García-Grande, Cara L Haymaker, Ignacio I Wistuba, Atocha Romero, Fernando F Franco, Mariano Provencio Pulla
Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial. Clinical and translational medicine 11 (7) (2022)
Javier Oliver, Juan-Luis Onieva-Zafra, Maria Garrido-Barros, Miguel-Angel Berciano-Guerrero, Alfonso Sánchez-Muñoz, María José Lozano, Angela Farngren, Martina Alvarez, Beatriz Martínez-Gálvez, Elisabeth Perez-Ruiz, Emilio Alba, Manuel Cobo, Antonio Rueda-Domínguez, Isabel Barragán
Association of Circular RNA and Long Non-Coding RNA Dysregulation with the Clinical Response to Immune Checkpoint Blockade in Cutaneous Metastatic Melanoma. Biomedicines 10 (10) (2022)
Juan-Luis Onieva-Zafra, Qingyang Xiao, Miguel-Angel Berciano-Guerrero, Aurora Laborda-Illanes, Carlos de Andrea, Patricia Chaves, Pilar Piñeiro, Alicia Garrido-Aranda, Elena Gallego, Belén Sojo, Laura Gálvez Carvajal, Rosario Chica-Parrado, Juan Daniel Prieto Cuadra, Elisabeth Perez-Ruiz, Angela Farngren, María José Lozano, Martina Alvarez, Pedro Jiménez, Alfonso Sánchez-Muñoz, Javier Oliver, Manuel Cobo, Emilio Alba, Isabel Barragán
High IGKC-Expressing Intratumoral Plasma Cells Predict Response to Immune Checkpoint Blockade. International journal of molecular sciences 23 (16) (2022)
Marta Casarrubios, Mariano Provencio Pulla, Ernest Nadal, Amelia Insa, María Del Rosario García-Campelo, Martín Lázaro, Manuel Dómine, Margarita Majem Tarruella, Delvys Rodríguez-Abreu, Alex Martinez-Marti, Javier De Castro Carpeño, Manuel Cobo, Guillermo López-Vivanco, Elvira Del Barco, Reyes Bernabé, Nuria Viñolas, Isidoro Barneto Aranda, Bartomeu Massuti, Belén Sierra-Rodero, Cristina Martinez-Toledo, Ismael Fernández-Miranda, Roberto Serna-Blanco, Atocha Romero, Virginia Calvo, Alberto Cruz-Bermúdez
Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy. Journal for immunotherapy of cancer 10 (9) (2022)
Marta Casarrubios, Alberto Cruz-Bermúdez, Ernest Nadal, Amelia Insa, María Del Rosario García Campelo, Martín Lázaro, Manuel Dómine, Margarita Majem, Delvys Rodríguez-Abreu, Alex Martinez-Marti, Javier De Castro Carpeño, Manuel Cobo, Guillermo López-Vivanco, Elvira Del Barco, Reyes Bernabé Caro, Nuria Viñolas, Isidoro Barneto Aranda, Santiago Viteri, Bartomeu Massuti, Miguel Barquín, Raquel Laza-Briviesca, Belén Sierra-Rodero, Edwin Roger Parra Cuentes, Beatriz Sanchez-Espiridion, Pedro Rocha, Humam Kadara, Ignacio I Wistuba, Atocha Romero, Virginia Calvo, Mariano Provencio
Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (21) (2021)
Margarita Majem Tarruella, Manuel Cobo, Dolores Isla, Diego Marquez-Medina, Delvys Rodriguez-Abreu, Joaquín Casal-Rubio, Teresa Moran Bueno, Reyes Bernabé-Caro, Diego Pérez Parente, Pedro Ruiz-Gracia, Marta Marina Arroyo, Luis Paz-Ares
PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis. Journal of clinical medicine 10 (7) (2021)
Sofía Ruiz-Medina, Silvia Gil, Begoña Jimenez, Pablo Rodriguez-Brazzarola, Tamara Diaz-Redondo, Mireya Cazorla, Marta Muñoz-Ayllon, Inmaculada Ramos, Carmen Reyna, María José Bermejo, Ana Godoy, Esperanza Torres, Manuel Cobo, Laura Galvez, Antonio Rueda, Emilio Alba, Nuria Ribelles
Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study. Cancers 13 (13) (2021)
Manuel Cobo, Carmen Beato Zambrano, Luis Cabezón-Gutiérrez, Rodolfo Chicas-Sett, María Isabel Blancas López-Barajas, Francisco Javier García Navalón, José Luis Fírvida Pérez, Gala Serrano Bermúdez, Pilar Togores Torres, Ignacio Delgado Mingorance, Alexandra Giraldo Marín, Anna Librán Oriol, Alfredo Paredes Lario, Pedro Sánchez Mauriño, Oliver Higuera Gómez, Diana Moreno Muñoz, Ibone Huerta González, Almudena Sanz-Yagüe, Begoña Soler-López
One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study. BMJ supportive & palliative care (2021)
Macarena Arroyo Varela, R Larrosa, J Gómez-Maldonado, Manuel Cobo, Manuel Gonzalo Claros, Rocio Bautista
Expression-based, consistent biomarkers for prognosis and diagnosis in lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (10) (2020)
Qingyang Xiao, André Nobre, Pilar Piñeiro, Miguel-Ángel Berciano-Guerrero, Emilio Alba, Manuel Cobo, Volker Martin Lauschke, Isabel Barragán
Genetic and Epigenetic Biomarkers of Immune Checkpoint Blockade Response. Journal of clinical medicine 9 (1) (2020)
Manuel Cobo, Carmen Beato Zambrano, Luis Cabezón Gutiérrez, Rodolfo Chicas Sett, María Isabel Blancas López-Barajas, Francisco García Navalón, José Luis Fírvida Pérez, Gala Serrano Bermúdez, Pilar Togores Torres, Ignacio Delgado Mingorance, Alexandra Giraldo Marín, Anna Librán Oriol, Alfredo Paredes Lario, Pedro Sánchez Mauriño, Oliver Higuera Gómez, Diana Moreno Muñoz, Antonio Javier Jiménez López, Ibone Huerta González, Almudena Sanz Yagüe, Begoña Soler-López
Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis. BMJ supportive & palliative care 11 (1) (2020)

Manuel Cobo.css-eqlu8i{font-size:small;padding-left:4px;} (M Á Cobo, Manuel Cobo-Dols, Manuel Cobo Dols)

Publication Activity (10 Years)

Top Topics

Top Venues

Manuel Cobo (M Á Cobo, Manuel Cobo-Dols, Manuel Cobo Dols)